trans N-Benzyl Paroxetine (CAS No. 105813-14-7) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of 按批次COA提供(不公开发布). Main applications include Organic Chemicals. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.
Organic Chemicals
COA provided with every batch; MSDS and technical documents available on request. Email us with product name and CAS number for a quote within one business day.
The CAS number of trans N-Benzyl Paroxetine is 105813-14-7.
Typical purity is 按批次COA提供(不公开发布), supplied in 按订单/批次确认(不公开发布), with COA provided.
Main applications include Organic Chemicals.
Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..
trans N-Benzyl Paroxetine · CAS 105813-14-7 · C26H26FNO3. UNII MLV7RU9XDD.
| CAS Registry Number | 105813-14-7 |
|---|---|
| PubChem CID | 9953865 |
| Molecular formula | C26H26FNO3 |
| IUPAC name | (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-1-benzyl-4-(4-fluorophenyl)piperidine |
| UNII (FDA) | MLV7RU9XDD |
| Molecular Weight | 419.5 |
|---|---|
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 419.18967185 |
| Monoisotopic Mass | 419.18967185 |
| Topological Polar Surface Area | 30.9 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H317 (100%), H332 (100%), H373 (100%), H400 (100%), H410 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
(3S,4r)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine; (3S,4R)-3-((1,3-Benzodioxol-5-yloxy)methyl)-1-benzyl-4-(4-fluorophenyl)piperidine; RefChem:401511; 929-011-7; 105813-14-7; (-)-N-Benzylparoxetine; N-Benzylparoxetine; MLV7RU9XDD; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-1-benzyl-4-(4-fluorophenyl)piperidine; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-1-benzyl-4-(4-fluorophenyl)piperidine; (3S,4R)-3-(((1,3-Benzodioxol-5-yl)oxy)methyl)-1-benzyl-4-(4-fluorophenyl)piperidine; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-(phenylmethyl)-, (3S,4R)-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-(phenylmethyl)-, trans-(-)-; starbld0017939; UNII-MLV7RU9XDD; (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-benzyl-4-(4-fluorophenyl)piperidine hydrochloride
CAS 105813-14-7; molecular formula C26H26FNO3; molecular weight — g/mol.
(3S,4r)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine, (3S,4R)-3-((1,3-Benzodioxol-5-yloxy)methyl)-1-benzyl-4-(4-fluorophenyl)piperidine, RefChem:401511, 929-011-7, 105813-14-7, (-)-N-Benzylparoxetine.
Hazard statements reported: H302, H317, H332, H373, H400.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.
Supplier: Jinan Shenghe Chemical Co., Ltd. · Reply within one business day.